Education

Bosch Health Campus Monthly Research Seminar

This seminar series will usually take place on the last Wednesday of the month at 16:00 in the RBK Hörsaal (with some exceptions). It will feature prominent speakers related to the various biomedical research foci within the Robert Bosch Gesellschaft für medizinische Forschung (RBMF). It will feature appointments from the Dr. Margarete Fischer-Bosch Institut für Klinische Pharmakologie (IKP), Robert Bosch Centrum für Tumorerkrankungen (RBCT) and the Robert Bosch Centrum für Integrative Medizin und Gesundheit (RBIM).

2024


 

28.02.2024          Dr. med. Dr. med. univ. Jan Valentini, Universitätsklinikum Tübingen 
                                  Decoding Acupuncture: Exploring the Neuro-Psycho-Endocrine-Immunological-Axis - Current
                                  Evidence and Insights

27.03.2024           Prof. Dr. Robert Lukowski, Experimentelle Pharmakologie, Institut für Pharmazie, Tübingen
                                   Breast cancer-promoting effects of (mitochondrial) BKCa K+ channels: A journey through
                                   metabolic reprogramming and hormone therapy

13.05.2024           Prof. Nicoletta Bobola, Faculty of Biology, Medicine and Health, University of Manchester
                                   Ubiquitous transcriptional regulators: master keys to unlock lineage differentiation

29.05.2024           Dr. med. Jan Vagedes M.A. Chefarzt, Pädiatrie, Filderklinik Wissenschaftlicher Leiter des
                                  ARCIM Institute sowie wissenschaftlicher Mitarbeiter der Uni Tübingen ARCIM Institute 
                                  Heart Rate Variability as a tool to measure stress levels of our autonomic nerve system

25.01.2023           Prof. Dr. Jörg Lausen, Uni-Stuttgart
                                   Gene expression control in differentiation and disease

22.02.2023           Prof. Dr. Gustav Dobos vom Zentrum für Naturheilkunde und Integrative Medizin des Universitätsklinikums Essen
                                   Planetary Health Diet: Healthy eating for people and planet - What is the evidence?

29.03.2023           Prof. Dr. André Martins, Uniklinikum Tübingen, W3 Full Professor in Advanced Preclinical Metabolic Imaging
                                   and Cell Engineering, 
member of the Cluster of Excellence iFIT (EXC2180)
                                   Harnessing metabolic imaging to monitor cancer aggressiveness non-invasively in vivo

26.04.2023           PD Dr. med. Daniel Lipka, Section Translational Cancer epigenomics, DKFZ and NCT Heidelberg
                                   RAS-Pathway Mutations Drive Onco-Fetal Reprogramming in Juvenile Myelomonocytic Leukemia

28.06.2023           Prof. Dr. Verena Labi, Medical University of Innsbruck Institute of Developmental Immunology
                                   Roles of epigenetic TET enzymes in hematologic cancers and immunity

27.09.2023           Prof. Dr. Sonja Loges, Medical Faculty Mannheim, University of Heidelberg and Chair of the Department of
                                   Personalized Oncology, University Hospital Mannheim
                                   Precision Oncology – from bench to bedside

28.09.2023           Dr. Jeremy Y. Ng, MSc, PhD, Postdoctoral Fellow, Centre for Journalology, Ottawa Methods Centre,
                                   Ottawa Hospital Research Institute, Ottawa, Canada     
                                   Basic Principles in Scholarly Publishing and Open Science Practices: A Primer

25.10.2023           Prof. Dr. Thomas Ostermann, Chair of Research Methodology and Statistics in Psychology, Department of Psychology
                                   and Psychotherapy,  F
aculty of Health, Witten/Herdecke University
                                   Regression to the mean – A statistical phenomenon, its occurrence and detection

29.11.2023           Prof. Dr. Lisa Maier, Interfaculty Institute of Microbiology and Infection Medicine, University of Tübingen
                                   The consequences of drugging the gut microbiome – from the individual microbe to the host